TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16875850

Group type: EXPERIMENTAL
Intervention: Duplex ultrasound scanning (DUSS)
Number of subjects: 310

Group type: COMPARATOR
Intervention: CT scanning
Number of subjects: 310
Study: 12621482

Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy plus stem-cell transplantation
Number of subjects: 180

Group type: COMPARATOR
Intervention: Conventional-dose chemotherapy
Number of subjects: 180
Study: 11049776

Group type: EXPERIMENTAL
Intervention: Home sampling
Number of subjects: 1700

Group type: COMPARATOR
Intervention: Conventional swab sampling
Number of subjects: 1700
Study: 9126306

Group type: EXPERIMENTAL
Intervention: Granisetron alone (40 micrograms/kg)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Granisetron, methylprednisolone (250 mg/body), and droperidol (0.5 ml/body)
Number of subjects: 34
Study: 8471555

Group type: EXPERIMENTAL
Intervention: Sequential methotrexate (250 mg/m2) and 5-fluorouracil (500 mg/m2) followed by leucovorin (15 mg x 8) (MFL)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Sequential 5-fluorouracil (500 mg/m2) followed by leucovorin (60 mg/m2) (FLv)
Number of subjects: 202
Study: 2956392

Group type: EXPERIMENTAL
Intervention: 200 mmol sodium/day
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 15 mmol sodium/day (plus frusemide, 40 mg on day 1)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 80 mmol sodium/day
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 120 mmol sodium/day
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both diet phases (200 mmol and 15 mmol sodium/day)
Number of subjects: 16
Study: 30760250

Group type: EXPERIMENTAL
Intervention: Cognitive remediation intervention delivered in 12 one-hour group-based sessions over six weeks.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive remediation intervention
Number of subjects: 0
Study: 30267987

Group type: EXPERIMENTAL
Intervention: Docetaxel (100 mg/m2)
Number of subjects: 762

Group type: EXPERIMENTAL
Intervention: Ixabepilone (40 mg/m2)
Number of subjects: 762
Study: 26416127

Group type: EXPERIMENTAL
Intervention: Mailed interactive DVD
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Computer-tailored telephone counseling
Number of subjects: 244

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 244
Study: 24491807

Group type: EXPERIMENTAL
Intervention: Group-1 (no history of otitis media)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Group-2 (history of otitis media)
Number of subjects: 33
Study: 22861198

Group type: EXPERIMENTAL
Intervention: Water aerosol of an alpine waterfall for 1 hour per day
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control site for 1 hour per day
Number of subjects: 54
Study: 21029895

Group type: EXPERIMENTAL
Intervention: +3.00 D IOL
Number of subjects: 32

Group type: COMPARATOR
Intervention: +4.00 D IOL
Number of subjects: 32
Study: 18940491

Group type: EXPERIMENTAL
Intervention: Radial forearm flap
Number of subjects: 20

Group type: COMPARATOR
Intervention: Anterolateral thigh flap
Number of subjects: 20
Study: 15913717

Group type: EXPERIMENTAL
Intervention: Vaginal measurement of intra-abdominal pressure (Pvag)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Rectal measurement of intra-abdominal pressure (Prec)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both methods (Pvag and Prec)
Number of subjects: 100
Study: 12111492

Group type: EXPERIMENTAL
Intervention: Isoflurane anesthesia
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Propofol anesthesia
Number of subjects: 12
Study: 10198865

Group type: EXPERIMENTAL
Intervention: Cooled intraocular irrigating solution (approximately 10 degrees C)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Room temperature irrigating solution
Number of subjects: 40
Study: 8579349

Group type: EXPERIMENTAL
Intervention: Intraoperative progress reports (5-10 minutes)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Usual care (Control group)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Attention protocol (Attention group)
Number of subjects: 150
Study: 2180471

Group type: COMPARATOR
Intervention: melphalan-prednisone (MP)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: multidrug chemotherapy (MDC)
Number of subjects: 164
Study: 7437260

Group type: EXPERIMENTAL
Intervention: Herbal cigarette
Number of subjects: 6

Group type: COMPARATOR
Intervention: Tobacco cigarette
Number of subjects: 6
Study: 31687751

Group type: EXPERIMENTAL
Intervention: Self-reported physical activity (IPAQ-short)
Number of subjects: 235
Study: 31123069

Group type: EXPERIMENTAL
Intervention: Low-sodium peritoneal dialysis fluid (125 mmol/L Na)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Standard-sodium peritoneal dialysis fluid (134 mmol/L Na)
Number of subjects: 82
Study: 28104097

Group type: EXPERIMENTAL
Intervention: 5% NaHCO3 and distilled water solution at 40-45°C
Number of subjects: 143

Group type: COMPARATOR
Intervention: 75% alcohol
Number of subjects: 143
Study: 25882712

Group type: EXPERIMENTAL
Intervention: TTM between 32.5 and 33.5°C (therapeutic hypothermia)
Number of subjects: 584

Group type: COMPARATOR
Intervention: TTM between 36.5 and 37.5°C (therapeutic normothermia)
Number of subjects: 584
Study: 24066023

Group type: EXPERIMENTAL
Intervention: Standard magnetic wrist strap (1502 to 2365 gauss)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Demagnetised wrist strap (<20 gauss)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Attenuated magnetic wrist strap (250 to 350 gauss)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Copper bracelet
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo (demagnetised wrist strap)
Number of subjects: 70
Study: 21841287

Group type: EXPERIMENTAL
Intervention: I Can Cope cancer education program
Number of subjects: 140
Study: 19236457

Group type: EXPERIMENTAL
Intervention: Subcutaneous immunoglobulin (SCIG)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Intravenous immunoglobulin (IVIG)
Number of subjects: 9
Study: 17177056

Group type: EXPERIMENTAL
Intervention: Albendazole (15 mg/kg/day for 2 weeks)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Albendazole
Number of subjects: 66
Study: 15109505

Group type: EXPERIMENTAL
Intervention: High frequency, low intensity TENS (HFT)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: High frequency, high intensity TENS (HIT)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control TENS (COT)
Number of subjects: 180
Study: 11692055

Group type: EXPERIMENTAL
Intervention: PPI plus clarithromycin plus amoxycillin for 7 days
Number of subjects: 481

Group type: EXPERIMENTAL
Intervention: RBC plus clarithromycin plus amoxycillin for 7 days
Number of subjects: 481

Group type: EXPERIMENTAL
Intervention: RBC plus clarithromycin plus amoxycillin plus metronidazole for 5 days
Number of subjects: 481

Group type: COMPARATOR
Intervention: Overall eradication in NUD patients
Number of subjects: 481

Group type: COMPARATOR
Intervention: Overall eradication in PUD patients
Number of subjects: 481

Group type: EXPERIMENTAL
Intervention: RBC plus clarithromycin plus amoxycillin for 7 days in NUD
Number of subjects: 481
Study: 9146316

Group type: EXPERIMENTAL
Intervention: Autotransfusion of shed mediastinal blood for 18 hours
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 135
Study: 7939142

Group type: EXPERIMENTAL
Intervention: Allergic children
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Allergic adults
Number of subjects: 121

Group type: COMPARATOR
Intervention: Non-allergic children
Number of subjects: 121

Group type: COMPARATOR
Intervention: Non-allergic adults
Number of subjects: 121
Study: 3070049

Group type: EXPERIMENTAL
Intervention: 250mg of caffeine
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 31397204

Group type: EXPERIMENTAL
Intervention: Preoperative enema (n=114)
Number of subjects: 225

Group type: COMPARATOR
Intervention: No preoperative enema (n=111)
Number of subjects: 225
Study: 30816573

Group type: EXPERIMENTAL
Intervention: miR-497-5p overexpression
Number of subjects: 2

Group type: COMPARATOR
Intervention: miR-497-5p inhibition
Number of subjects: 2

Group type: COMPARATOR
Intervention: SOX5 overexpression
Number of subjects: 2
Study: 30261083

Group type: EXPERIMENTAL
Intervention: Care-seeking from trained providers
Number of subjects: 2868
Study: 27091825

Group type: EXPERIMENTAL
Intervention: Supported communication for aphasia training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 20
Study: 24661836

Group type: EXPERIMENTAL
Intervention: Whole grain rye crisp bread (RB)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Refined wheat bread (WB)
Number of subjects: 41
Study: 22185963

Group type: EXPERIMENTAL
Intervention: HX575 (subcutaneous administration)
Number of subjects: 337

Group type: COMPARATOR
Intervention: Erypo®/Eprex® (control group)
Number of subjects: 337
Study: 20685806

Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation with walking visual illusion
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Visual illusion
Number of subjects: 39

Group type: COMPARATOR
Intervention: Sham stimulation with visual illusion
Number of subjects: 39

Group type: COMPARATOR
Intervention: Sham stimulation with control illusion
Number of subjects: 39

Group type: COMPARATOR
Intervention: Transcranial direct current stimulation with control illusion
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Combined treatment (transcranial direct current stimulation and visual illusion)
Number of subjects: 39
Study: 18204328

Group type: EXPERIMENTAL
Intervention: Antithrombin (AT) supplementation
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Continuous infusion of AT
Number of subjects: 27

Group type: COMPARATOR
Intervention: Bolus method of AT supplementation
Number of subjects: 27
Study: 15791603

Group type: EXPERIMENTAL
Intervention: Interview-assisted standardized questionnaire
Number of subjects: 114

Group type: COMPARATOR
Intervention: Self-completed standardized questionnaire
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Interview-assisted questions
Number of subjects: 114

Group type: COMPARATOR
Intervention: Self-completion
Number of subjects: 114
Study: 12038935

Group type: EXPERIMENTAL
Intervention: Type 1 e‐journals (completely electronic with no print counterpart)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Type 2 e‐journals (print and electronic versions with unique content)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Type 3 e‐journals (print and electronic versions containing equal content)
Number of subjects: 45

Group type: COMPARATOR
Intervention: All types of e‐journals
Number of subjects: 45
Study: 10887868

Group type: EXPERIMENTAL
Intervention: Certification program for nurses
Number of subjects: 193

Group type: COMPARATOR
Intervention: Visual glucose oxidase strip (Chemstrip) procedure
Number of subjects: 193
Study: 7737266

Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg/day for at least 1 year
Number of subjects: 59

Group type: COMPARATOR
Intervention: No treatment (lipid-lowering diet only)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Healthy male volunteers (normocholesterolaemic controls)
Number of subjects: 59
Study: 2405735

Group type: EXPERIMENTAL
Intervention: pH-adjusted bupivacaine with hyaluronidase 15 units/ml (pH 6.82 +/‐ 0.09)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Plain bupivacaine with hyaluronidase (pH 5.45 +/‐ 0.12)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (plain bupivacaine)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: pH-adjusted bupivacaine
Number of subjects: 35
Study: 6107766

Group type: EXPERIMENTAL
Intervention: Mestranol (mean 23 x 3 micrograms/day)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 31501092

Group type: EXPERIMENTAL
Intervention: Optimal start dialysis group (DIFE value between 30 and 35)
Number of subjects: 388

Group type: COMPARATOR
Intervention: Late-start dialysis group (DIFE value less than 30)
Number of subjects: 388

Group type: EXPERIMENTAL
Intervention: Optimal start dialysis group
Number of subjects: 388

Group type: COMPARATOR
Intervention: Late-start dialysis group
Number of subjects: 388
Study: 28403475

Group type: EXPERIMENTAL
Intervention: Complete abstinence from smoking
Number of subjects: 381

Group type: COMPARATOR
Intervention: Smoking > 0 < 5 cpd
Number of subjects: 381

Group type: COMPARATOR
Intervention: Smoking 5-9 cpd
Number of subjects: 381

Group type: COMPARATOR
Intervention: Smoking ≥10 cpd
Number of subjects: 381
Study: 25677337

Group type: EXPERIMENTAL
Intervention: Unconscious thought condition (participants were distracted for 3 minutes)
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Unconscious thought condition
Number of subjects: 173

Group type: COMPARATOR
Intervention: Conscious thought condition (participants instructed to think about the information for 3 minutes)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Immediate decision condition (participants moved directly to the decision task)
Number of subjects: 173
Study: 24315811

Group type: EXPERIMENTAL
Intervention: Preterm newborns (n=22) reaching term age (38-42 weeks)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Matched controls (term newborns)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Preterm newborns (first EEG)
Number of subjects: 47
Study: 21840129

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (OT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intranasal vasopressin (AVP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19123933

Group type: EXPERIMENTAL
Intervention: Active treatment
Number of subjects: 2900

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2900

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 2900
Study: 18173093

Group type: EXPERIMENTAL
Intervention: Xylitol (6.2 g/day)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Sorbitol/maltitol (control)
Number of subjects: 109
Study: 15133882

Group type: EXPERIMENTAL
Intervention: Management intervention programs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference group of matched physicians
Number of subjects: 0
Study: 12031189

Group type: EXPERIMENTAL
Intervention: Nutrition science college course (n = 21)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no course, n = 19)
Number of subjects: 40
Study: 9674374

Group type: EXPERIMENTAL
Intervention: Amended instructions linking direction instructions to landmarks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Full guidance instructions
Number of subjects: 80

Group type: COMPARATOR
Intervention: No guidance instructions
Number of subjects: 80

Group type: COMPARATOR
Intervention: Driving experience of 1 year or less
Number of subjects: 80
Study: 8018401

Group type: EXPERIMENTAL
Intervention: Cisplatin-based chemotherapy with doxorubicin
Number of subjects: 111

Group type: COMPARATOR
Intervention: Cisplatin-based chemotherapy without doxorubicin
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Cisplatin-based chemotherapy
Number of subjects: 111
Study: 2644855

Group type: EXPERIMENTAL
Intervention: 200 mg ferrous sulfate twice daily for 16 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 1115173

Group type: EXPERIMENTAL
Intervention: Progesterone-releasing IUD
Number of subjects: 201

Group type: COMPARATOR
Intervention: Non-steroid IUD
Number of subjects: 201
Study: 31800355

Group type: EXPERIMENTAL
Intervention: 0.01% atropine
Number of subjects: 176

Group type: COMPARATOR
Intervention: 0.5% hydroxypropyl‐methylcellulose (control)
Number of subjects: 176
Study: 31220698

Group type: EXPERIMENTAL
Intervention: Light sleep
Number of subjects: 149

Group type: COMPARATOR
Intervention: Wakefulness
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Multispectral EEG index during light sleep
Number of subjects: 149
Study: 28035868

Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg once daily for 24 weeks
Number of subjects: 381

Group type: COMPARATOR
Intervention: Placebo once daily for 24 weeks
Number of subjects: 381
Study: 25885266

Group type: EXPERIMENTAL
Intervention: Clinical decision-support reminders for medical providers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no reminders)
Number of subjects: 0
Study: 23639513

Group type: EXPERIMENTAL
Intervention: Olmesartan/Amlodipine fixed-dose combination (OA)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Amlodipine double dose (DA)
Number of subjects: 141
Study: 21525201

Group type: EXPERIMENTAL
Intervention: Weight suppression
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Suppressed resting metabolic rate (RMR)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Suppressed total energy expenditure (TEE)
Number of subjects: 91
Study: 18283518

Group type: EXPERIMENTAL
Intervention: Bassini repair
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: Shouldice repair
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: Lichtenstein repair
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: TAPP
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: TEP
Number of subjects: 365

Group type: COMPARATOR
Intervention: Open techniques (Bassini, Shouldice, Lichtenstein)
Number of subjects: 365

Group type: COMPARATOR
Intervention: Laparoscopic techniques (TAPP, TEP)
Number of subjects: 365

Group type: COMPARATOR
Intervention: Mesh techniques (Lichtenstein, TAPP, TEP)
Number of subjects: 365

Group type: COMPARATOR
Intervention: Suturing techniques (Bassini, Shouldice)
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: Intraoperative complications
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: Perioperative complications
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: Long-term complications
Number of subjects: 365
Study: 16948487

Group type: EXPERIMENTAL
Intervention: Strength training and nutritional counseling (n = 25)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Strength training only (n = 26)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Strength training
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Nutritional counseling
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Strength training and nutritional counseling
Number of subjects: 51
Study: 12716247

Group type: EXPERIMENTAL
Intervention: Lithium augmentation (LA)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Cognitive therapy (CT)
Number of subjects: 44
Study: 10836195

Group type: EXPERIMENTAL
Intervention: Monophasic gestodene (Minulet)
Number of subjects: 2419

Group type: EXPERIMENTAL
Intervention: Triphasic gestodene (Tri‐Minulet)
Number of subjects: 2419

Group type: EXPERIMENTAL
Intervention: Monophasic desogestrel (Mercilon)
Number of subjects: 2419

Group type: COMPARATOR
Intervention: Desogestrel (Mercilon)
Number of subjects: 2419
Study: 9109072

Group type: EXPERIMENTAL
Intervention: 0.5% ketorolac tromethamine (Acular) in the multiple-drop group
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 0.1% diclofenac sodium (Voltaren) in the multiple-drop group
Number of subjects: 30

Group type: COMPARATOR
Intervention: 0.5% ketorolac tromethamine (Acular) in the two-drop group
Number of subjects: 30

Group type: COMPARATOR
Intervention: 0.1% diclofenac sodium (Voltaren) in the two-drop group
Number of subjects: 30
Study: 1394532

Group type: EXPERIMENTAL
Intervention: Betoptic
Number of subjects: 10

Group type: COMPARATOR
Intervention: Timoptol
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 3900975

Group type: EXPERIMENTAL
Intervention: Aspirin (325 mg q.o.d.)
Number of subjects: 22071

Group type: EXPERIMENTAL
Intervention: Beta-carotene (50 mg q.o.d.)
Number of subjects: 22071

Group type: COMPARATOR
Intervention: Placebo (for both interventions)
Number of subjects: 22071
Study: 31803192

Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 25

Group type: COMPARATOR
Intervention: Azathioprine
Number of subjects: 25

Group type: COMPARATOR
Intervention: Mycophenolate mofetil
Number of subjects: 25
Study: 29075849

Group type: EXPERIMENTAL
Intervention: Paleolithic-type diet (PD)
Number of subjects: 58
Study: 27311399

Group type: EXPERIMENTAL
Intervention: Intensity Modulated Radiation Therapy (IMRT) with level V lymphatics (LVN) included
Number of subjects: 408

Group type: COMPARATOR
Intervention: Intensity Modulated Radiation Therapy (IMRT) with level V lymphatics (LVN) omitted
Number of subjects: 408
Study: 24650400

Group type: EXPERIMENTAL
Intervention: Nonculprit MBG 0/1
Number of subjects: 6921

Group type: EXPERIMENTAL
Intervention: Nonculprit MBG 0/1 with TIMI flow grade 3 in culprit vessel
Number of subjects: 6921
Study: 22205035

Group type: EXPERIMENTAL
Intervention: High-frequency percussive ventilation (HFPV)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Conventional ventilation (CV)
Number of subjects: 35
Study: 20103391

Group type: EXPERIMENTAL
Intervention: Tai Chi Chuan program
Number of subjects: 28

Group type: COMPARATOR
Intervention: Balance training program
Number of subjects: 28
Study: 18005381

Group type: EXPERIMENTAL
Intervention: Intravenous PCA with remifentanil
Number of subjects: 52

Group type: COMPARATOR
Intervention: Epidural analgesia with 20 ml levobupivacaine 0.625 mg/ml and fentanyl 2 microg/ml
Number of subjects: 52
Study: 16099291

Group type: EXPERIMENTAL
Intervention: C4A-rich plasma priming (20 mL/kg)
Number of subjects: 116

Group type: COMPARATOR
Intervention: C4A-free plasma priming (20 mL/kg)
Number of subjects: 116

Group type: COMPARATOR
Intervention: C4A-free plasma priming
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: C4A-rich plasma priming
Number of subjects: 116
Study: 11868640

Group type: EXPERIMENTAL
Intervention: Vaginal delivery with third- or fourth-degree perineal tears
Number of subjects: 949

Group type: EXPERIMENTAL
Intervention: Forceps delivery
Number of subjects: 949

Group type: EXPERIMENTAL
Intervention: Anal sphincter tears
Number of subjects: 949

Group type: EXPERIMENTAL
Intervention: First vaginal birth
Number of subjects: 949

Group type: EXPERIMENTAL
Intervention: Median episiotomy
Number of subjects: 949

Group type: EXPERIMENTAL
Intervention: Vacuum-assisted delivery
Number of subjects: 949

Group type: EXPERIMENTAL
Intervention: Birth weight 4000 g or more
Number of subjects: 949

Group type: EXPERIMENTAL
Intervention: Length of the second stage of labour 1.5 hours or longer
Number of subjects: 949
Study: 10837909

Group type: EXPERIMENTAL
Intervention: DIABNET decision support system
Number of subjects: 9